A product image of a smart insole developed with a graphene sensing system that...
A product image of a smart insole developed with a graphene sensing system that can help detect early signs of foot ulcers before they form

News • Diabetic feet prevention

Smart insole detects signs of foot ulcer

Stevens Institute of Technology has signed an exclusive licensing agreement with Bonbouton, giving the company the right to use and further develop a graphene sensing system that detects early signs of foot ulcers before they form, so diabetic patients can access preventative healthcare and manage their health.

Complications from diabetes can make it difficult for patients to monitor their foot health. Chronically high levels of blood glucose can impair blood vessels and cause nerve damage. Patients can experience a lot of pain, or worse, can lose the feeling in their feet. Diabetes-related damage to blood vessels and nerves can lead to hard-to-treat infections such as ulcers. Ulcers that don’t heal can cause severe damage to tissues and bone and may require amputation of a toe, foot or part of a leg. advised.

Insole fits with Sneaker or dress shoes

Bonbouton’s smart insoles can be inserted into a sneaker or dress shoe to passively monitor the foot health of a person living with diabetes. The insoles sense the skin’s temperature, pressure and other foot health-related data, which can alert a patient and his or her healthcare provider healthcare provider, who can determine whether a treatment is needed. This simplifies patient self-monitoring and reduces the frequency of doctor visits. “I was inspired by two things: a desire to help those with diabetes and a desire to commercialize the technology,” said Bonbouton Founder and CEO Linh Le, who developed and patented the core graphene technology while pursuing a doctorate in chemical engineering at Stevens.

Billions of dollars can be saved in healthcare costs

Le started to create an insole that could help prevent diabetic ulcers after several personal incidents lead him to pursue preventative healthcare. “I am excited to realize the full potential the technology that will bring seamless preventative care to patients and save billions of dollars in healthcare costs.”

Stevens is a shareholder of Bonbouton (legally known as FlexTraPower) and co-owns two of the seven patents filed by the company.

20.11.2019

Read all latest stories

Related articles

Photo

News • Regenerative medicine

Tapping into a tumor's power to heal non-healing wounds

Scientists have discovered a way to train healthy immune cells to acquire the skills of some tumor cells for a good purpose: to accelerate diabetic wound healing.

Photo

News • Microbial keratitis prevention

'Smart contact lenses' to detect eye infections

A pioneering ‘smart contact lens’ to test the eye in a quick, non-invasive way could prevent deaths caused by fungal eye infections in developing countries.

Photo

News • Ultrathin fuel cell

Using the body’s own sugar to power implants and sensors

Glucose is absorbed from the foods we eat and fuels every cell in our bodies. But could it also power tomorrow’s medical implants? According to a team of engineers, it might.

Related products

Sarstedt – Low DNA Binding Micro Tubes

Research Use Only

Sarstedt – Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG
Shimadzu – CLAM-2030 CL (IVD)/ CLAM-2030 (RUO)

Mass Spectrometry

Shimadzu – CLAM-2030 CL (IVD)/ CLAM-2030 (RUO)

Shimadzu Europa GmbH
Shimadzu – LCMS-8060NX CL (IVD) / LCMS-8060 NX (RUO)

Mass Spectrometry

Shimadzu – LCMS-8060NX CL (IVD) / LCMS-8060 NX (RUO)

Shimadzu Europa GmbH
Shimadzu – MALDImini-1

Research Use Only

Shimadzu – MALDImini-1

Shimadzu Europa GmbH
Subscribe to Newsletter